Rock Health is an incubator similar to Y Combinator, located in San Francisco, USA, providing entrepreneurial teams with office space, industry instructor guidance, startup funding and more. Rock Health recently published a report on genomics. The arterial network has been translated and reorganized, and it is expected to provide some inspiration for the increasingly competitive genomics application companies.
Genomics has enormous potential and will have a major impact on the healthcare industry . This is due to a large number of high-profile corporate and individual investments and initiatives, such as President Obama's proposal for precision medicine (1 million people joined this month), and consumers are beginning to pay more attention to genomics and its position in the medical industry. .
The genetic code is currently under development in the medical industry, and doctors, scientists and technicians in this field have a long way to go. In the course of writing this report, we found that genomics is at an important turning point. Despite the breakthrough in gene sequencing technology, the cost of sequencing is also significantly reduced, but gene sequencing is not very attractive to the public, and it is not closely integrated with medical institutions such as hospitals.
The development prospects of genomics depend mainly on three factors, mostly related to digital medicine:
(1) Ensure the diversity of sources of data sets that provide insights
(2) Breaking down barriers to cooperation with medical institutions
(3) Promote scientific and technological progress in the laboratory and the cloud
To understand the potential methods and current barriers to the promotion of genomics, we interviewed a thousand consumers, provided new data and insights about the willingness to purchase specific use cases, and explored privacy and ownership issues.
There is no doubt that genomics will improve the medical industry and promote personalized medicine. But the science of genomics has been esoteric for decades. Therefore, it is equally difficult to extend genomics to the medical care industry. We hope to provide some inspiration for the promotion of genomics and technological advancement through research.
Research Background
Sajith Wickramasekara, founder and CEO of Benchling, mentioned a question. Is it more appropriate to say that genetic data is more objective than other types of data? Will all data become binary result data? Although there are still a lot of unsolved mysteries, if we have tried other methods, this may be the final answer to those problems.
.jpg)
The influence of the field of genomics is enormous. This report examines the application of all medically relevant genetic data, including single nucleotide polymorphisms (SNPs), gene panels (a group of genes that are clinically meaningful after sequencing), and exomes (1-2% of genomes). Forming a protein) and a whole genome containing three million base pairs. Other biogroups (such as proteomics, metabolomics) are outside the scope of this report.
.jpg)
We use the terms “genomics†and “gene detection†in our report to distinguish the differences between terms: genomics is the study of large segments or genome-wide variations, while genetic testing involves only specific genes.
One of the primary goals of genomics is to provide personalized, actionable solutions to provide better care. Achieving such goals still requires understanding how genes and human health interact, and scientists need more diverse genetic and phenotypic data (such as personal information) and free access to relevant data sources.
When consumers buy direct-to-consumer (DTC) genomic products, such as choosing to go to the doctor's office to do genetic data in the genetic testing ecosystem, or participate in clinical tracking studies, genetic data in the ecosystem will increase. The genomic industry can and should encourage consumer engagement at these touch points. At present, this is mainly achieved through three methods: (1) understanding of the field of genomics (2) providing consumers with better genomic products (3) more relevant user use cases.
The US government has increased public awareness of genomics by funding grants for some of the most well-known proposals, such as precision medical proposals. Business companies have also made contributions, such as 23andMe, which is committed to providing products that are easier to access and easier to understand. Finally, diagnostic companies and research institutes such as The Broad Institution are planning new collaborative projects and using user stories to generate customer interest in personally oriented products.
.jpg)
We're Professional Supplier Extract Powder manufacturers and suppliers in China specialized in providing high-quality products at low price. We warmly welcome you to buy or wholesale bulk Supplier Extract Powder for sale here from our factory. For a free sample, contact us now.
Supplier Extract Powder,Supplier Extract ,Supplier Powder Manufacturer in China
Shaanxi Kang New Pharmaceutical co., Ltd. , https://www.anabolicsteriod.com